Choice of Antibiotics like Azithromycin/ Amoxicillin/Amoxicillin clavulonic acid/ Doxycycline/ Cefixime
"community-acquired pneumonia"[MeSH] AND "antibiotic therapy"[MeSH]
"community-acquired pneumonia" AND antibiotics AND outpatient
PMID: 38360961
PMID: 39243792
| Antibiotic | Class | Spectrum Summary |
|---|---|---|
| Amoxicillin | Aminopenicillin | Gram-positive cocci, some gram-negatives (not beta-lactamase producers) |
| Amoxicillin-Clavulanate | Aminopenicillin + BLI | Broader - includes beta-lactamase-producing H. influenzae, M. catarrhalis, S. aureus |
| Azithromycin | Macrolide | Atypical organisms (Mycoplasma, Chlamydophila, Legionella), some gram-positives |
| Doxycycline | Tetracycline | Atypicals (Mycoplasma, Chlamydophila), S. pneumoniae, some gram-negatives |
| Cefixime | 3rd-gen oral cephalosporin | Gram-negatives (H. influenzae, M. catarrhalis), some gram-positives - NOT anaerobes or atypicals |
2024 Network Meta-Analysis (PMID 38360961): Among oral antibiotics for mild-moderate CAP, levofloxacin and azithromycin ranked highest for mortality reduction; amoxicillin-clavulanate was also favored. Amoxicillin alone ranked lowest for clinical response. No antibiotic was conclusively superior - all confidence intervals broadly overlapped.
| Indication | 1st Choice | Alternative | Avoid |
|---|---|---|---|
| CAP (outpatient, typical) | Amoxicillin + Doxycycline | Amoxicillin-clavulanate | Azithromycin alone (resistance) |
| CAP (atypical suspected) | Azithromycin or Doxycycline | - | Amoxicillin alone |
| CAP (comorbidities) | Amoxicillin-clavulanate | Cefixime + Azithromycin | - |
| Acute Sinusitis | Amoxicillin-clavulanate | Amoxicillin (mild) / Doxycycline (PCN allergy) | Azithromycin |
| Acute Bronchitis | Supportive only (usually) | Doxycycline if needed | Routine antibiotics |
| H. influenzae bronchitis/LRTI | Amoxicillin-clavulanate or Cefixime | Azithromycin/Doxycycline | Amoxicillin alone |